Raia Drogasil SA Stock Sao Paulo
Stocks
DROG3
BRDROGACNOR1
Drug Retailers
OTC Markets Traded|
End-of-day quote
Sao Paulo
|
||
| - BRL | - |
|
| Nov. 04 | Raia Drogasil S.A., Q3 2026 Earnings Call, Nov 04, 2026 | |
| Nov. 03 | Raia Drogasil S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| Market Cap | 25.93B 4.72B 4.23B 3.87B 3.53B 6.65B 443B 6.86B 46.59B 18.58B 237B 17.7B 17.32B 747B | P/E 2026 * |
17.4x | P/E 2027 * | 13x |
|---|---|---|---|---|---|
| Enterprise Value | 34.85B 6.34B 5.69B 5.2B 4.74B 8.94B 596B 9.22B 62.63B 24.97B 318B 23.79B 23.28B 1,004B | EV / Sales 2026 * |
0.77x | EV / Sales 2027 * | 0.7x |
| Free-Float |
73.04% | Yield 2026 * |
2.32% | Yield 2027 * | 2.8% |
Last Transcript: Raia Drogasil SA
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2024-12-31 | |
| Director of Finance/CFO | 63 | 2013-04-28 | |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 50 | 2024-12-31 | |
| Director/Board Member | - | - | |
Gilberto Lerio
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.05% | +13.54% | -27.29% | +13.10% | 17.6B | ||
| -4.01% | +5.57% | -12.05% | +10.87% | 6.77B | ||
| -2.86% | +3.03% | -7.21% | +5.03% | 6.66B | ||
| -1.43% | +9.73% | -44.74% | -36.61% | 6.39B | ||
| +1.46% | +2.31% | +14.32% | -7.19% | 4.91B | ||
| -19.18% | -2.56% | -29.64% | -41.60% | 4.72B | ||
| +3.72% | +6.07% | +17.50% | -12.21% | 3.66B | ||
| -2.15% | +0.11% | -18.75% | -31.06% | 3.22B | ||
| -4.07% | +5.11% | -10.94% | -16.66% | 3.17B | ||
| Average | -3.16% | +4.76% | -13.20% | -12.92% | 6.35B | |
| Weighted average by Cap. | -2.52% | +6.91% | -17.45% | -5.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45B 8.18B 7.34B 6.71B 6.12B 11.54B 769B 11.9B 80.86B 32.24B 411B 30.72B 30.06B 1,296B | 51.04B 9.28B 8.33B 7.61B 6.95B 13.09B 873B 13.5B 91.72B 36.57B 466B 34.84B 34.1B 1,470B |
| Net income | 1.5B 272M 244M 223M 204M 384M 25.58B 396M 2.69B 1.07B 13.65B 1.02B 1B 43.09B | 2B 364M 327M 299M 273M 514M 34.26B 530M 3.6B 1.44B 18.28B 1.37B 1.34B 57.7B |
| Net Debt | 8.92B 1.62B 1.46B 1.33B 1.21B 2.29B 153B 2.36B 16.03B 6.39B 81.4B 6.09B 5.96B 257B | 9.62B 1.75B 1.57B 1.43B 1.31B 2.47B 165B 2.54B 17.29B 6.89B 87.78B 6.57B 6.43B 277B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- RADL3 Stock
- DROG3 Stock
Select your edition
All financial news and data tailored to specific country editions
















